Brief: Ultimovacs Receives US Patent And Trademark Office Notice Of Allowance
Aug 23 (Reuters) - Ultimovacs ASA ULTI.OL :
* SAID ON MONDAY, ULTIMOVACS STRENGTHENS IP PORTFOLIO WITH
THE
UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) NOTICE OF
ALLOWANCE ON UV1 METHOD PATENT
* COMPANY EXPECTS THAT PATENT WILL ISSUE WITH A TERM TO AT
LEAST
15 FEBRUARY 2031
Source text for Eikon: ID:nGNE7THjtQ
Further company coverage: ULTI.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant